WorldCat Identities

Ioannidis, John P.

Works: 10 works in 10 publications in 2 languages and 350 library holdings
Roles: Author, Editor
Publication Timeline
Most widely held works by John P Ioannidis
Evaluation of technologies for identifying acute cardiac ischemia in emergency departments by Joseph Lau( Book )

1 edition published in 2001 in English and held by 205 WorldCat member libraries worldwide

Diagnosis and treatment of uncomplicated acute sinusitis in children( Book )

1 edition published in 2000 in English and held by 137 WorldCat member libraries worldwide

Replication and meta-analysis of TMEM132D gene variants in panic disorder by A Erhardt( )

1 edition published in 2016 in English and held by 1 WorldCat member library worldwide

Translation, replication, and credibility of research findings by John P Ioannidis( Visual )

1 edition published in 2007 in English and held by 1 WorldCat member library worldwide

De eureka-industrie( Book )

1 edition published in 2016 in Dutch and held by 1 WorldCat member library worldwide

The pressure to get it right : biases in biomedical research by John P Ioannidis( Visual )

1 edition published in 2012 in English and held by 1 WorldCat member library worldwide

(CIT): Dr. Ioannidis will discuss the empirical evidence for the presence and consequences of some main biases in scientific discovery. He will also discuss solutions for optimizing the efficiency of the biomedical research processes. The intensified quest for scientific discovery has resulted in a flurry of research claims that represent false positive or exaggerated results. There are many forces that create this excess of spurious significant findings, including both random error and a number of biases. Dr. Ioannidis talk will address all of these pertinent issues. Dr. Ioannidis is currently the C.F. Rehnborg Professor in Disease Prevention, Professor of Medicine and Director of the Stanford Prevention Research Center at Stanford University School of Medicine. He has been adjunct faculty for the Tufts University School of Medicine since 1996, with the rank of professor since 2002, and since 2008 he has been leading the Center for Genetic Epidemiology and Modeling, of the Tufts Institute for Clinical Research and Health Policy Studies and the Genetics/Genomics component at the Tufts CTSI. He is also adjunct professor of epidemiology at the Harvard School of Public Health and visiting professor of epidemiology and biostatistics at Imperial College London. Dr. Ioannidis has served as a member of the executive board of the Human Genome Epidemiology Network, President of the Society for Research Synthesis Methodology, editorial board member of 26 leading international journals, and Editor-in-Chief of the European Journal of Clinical Investigation. He has published peer-reviewed papers, books and book chapters, papers such as the one in PLoS Medicine, "Why most Published Research Findings are False (2005). He has received several awards, including the European Award for Excellence in Clinical Science for 2007 and he has been inducted into the Association of American Physicians and the European Academy of Cancer Sciences. His work combines skills in clinical research methodology and evidence-based medicine with the challenges of current molecular medicine and genomics. This seminar is sponsored by the Office of Disease Prevention, National Heart, Lung, and Blood Institute, National Institute on Alcohol Abuse and Alcoholism, and National Cancer Institute Division of Cancer
Interpretation of quantitative research( Book )

1 edition published in 2008 in English and held by 1 WorldCat member library worldwide

Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer : application of the Venice interim guidelines by Environmental Carcinogens Group (GSEC)( )

1 edition published in 2010 in English and held by 1 WorldCat member library worldwide

Objective: There is an overwhelming abundance of genetic association studies available in the literature, which can often be collectively difficult to interpret. To address this issue, the Venice interim guidelines were established for determining the credibility of the cumulative evidence. The objective of this report is to evaluate the literature on the association of common glutathione S-transferase (GST) variants (GSTM1 null, GSTT1 null and GSTP1 Ile105Val polymorphism) and lung cancer, and to assess the credibility of the associations using the newly proposed cumulative evidence guidelines. Methods: Information from the literature was enriched with an updated meta-analysis and a pooled analysis using data from the Genetic Susceptibilityto Environmental Carcinogens database. Results: There was a significant association between GSTM1 null and lung cancer for the meta-analysis (meta odds ratio=1.17, 95% confidence interval: 1.10-1.25) and pooled analysis (adjusted odds ratio=1.10, 95% confidence interval: 1.04-1.16), although substantial heterogeneity was present. No overall association between lung cancer and GSTT1 null or GSTP1 Ile105Val was found. When the Venice criteria was applied, cumulative evidence for all associationswere considered 'weak', with the exception of East Asian carriers of the G allele of GSTP1 Ile105Val, which was graded as 'moderate' evidence. Conclusion: Despite the large amounts of studies, and several statistically significant summary estimates produced by meta-analyses, the application of the Venice criteria suggests extensive heterogeneity and susceptibility to bias for the studies on association of common genetic polymorphisms, such as with GST variants and lung cancer
Human Genome Epidemiology, 2nd Edition : Building the evidence for using genetic information to improve health and prevent disease( )

1 edition published in 2010 in English and held by 1 WorldCat member library worldwide

The first edition of Human Genome Epidemiology, published in 2004, discussed how the epidemiologic approach provides an important scientific foundation for studying the continuum from gene discovery to the development, applications and evaluation of human genome information in improving health and preventing disease. Since that time, advances in human genomics have continued to occur at a breathtaking pace. With contributions from leaders in the field from around the world, this new edition is a fully updated look at the ways in which genetic factors in common diseases are studied. Methodologic developments in collection, analysis and synthesis of data, as well as issues surrounding specific applications of human genomic information for medicine and public health are all discussed. In addition, the book focuses on practical applications of human genome variation in clinical practice and disease prevention. Students, clinicians, public health professionals and policy makers will find the book a useful tool for understanding the rapidly evolving methods of the discovery and use of genetic information in medicine and public health in the 21st century
A universal standard for the validation of blood pressure measuring devices( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

Abstract : N/A: In the last 30 years, several organizations, such as the US Association for the Advancement of Medical Instrumentation (AAMI), the British Hypertension Society, the European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and the International Organization for Standardization (ISO) have developed protocols for clinical validation of BP measuring devices. However, it is recognized that science, as well as patients, consumers and manufacturers would be best served if all BP measuring devices were assessed for accuracy according to an agreed single validation protocol that had global acceptance. Therefore, an international initiative was taken by AAMI, ESH and ISO experts who agreed to develop a universal standard for device validation. This statement presents the key aspects of a validation procedure, which were agreed by the AAMI, ESH and ISO representatives as the basis for a single universal validation protocol. As soon as the AAMI/ESH/ISO standard is fully developed, this will be regarded as the single universal standard and will replace all other previous standards/protocols
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.48 (from 0.44 for Evaluation ... to 0.97 for Replicatio ...)

Alternative Names
Ioannidis, J. P.

John Ioannidis

John P. A. Ioannidis epidemioloog uit Griekenland

John P. A. Ioannidis professor and chairman at the Department of Hygiene and Epidemiology


English (9)

Dutch (1)